{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:22:42Z","timestamp":1786994562592,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.mycmed.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T21:47:26Z","timestamp":1510350446000},"page":"218-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient"],"prefix":"10.1016","volume":"28","author":[{"given":"\u0130.","family":"Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6.","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ergani\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aydo\u011fdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dizbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"G\u00fcrsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kalkanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2017.09.003_bib0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mmcr.2017.02.002","article-title":"Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: in a child in intensive care unit and review of the literature","volume":"15","author":"At\u0131c\u0131","year":"2017","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0200","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1469-0691.2010.03398.x","article-title":"Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"17","author":"Bader","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0205","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/01.inf.0000189984.51944.cd","article-title":"Catheter-related fungemia caused by Saccharomyces cerevisiae in a newborn","volume":"24","author":"Belet","year":"2005","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0210","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/ajcn\/83.6.1256","article-title":"Probiotic use in clinical practice: what are the risks?","volume":"83","author":"Boyle","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0215","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/JCM.41.11.5340-5343.2003","article-title":"Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism","volume":"41","author":"Cassone","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0220","first-page":"504","article-title":"Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii","volume":"8","author":"Cesaro","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mmcr.2013.02.003","article-title":"Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation","volume":"2","author":"Cohen","year":"2013","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0230","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/tid.12587","article-title":"Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations","volume":"18","author":"Cohen","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0235","first-page":"108","article-title":"Saccharomyces cerevisiae infection \u2013 an unusual pathogen in the ICU","volume":"23","author":"da Silva","year":"2011","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijfoodmicro.2006.04.023","article-title":"Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections","volume":"110","author":"de Llanos","year":"2006","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/14740338.2014.872627","article-title":"A systematic review of the safety of probiotics","volume":"13","author":"Didari","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0250","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0255","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/AEM.02201-06","article-title":"Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae","volume":"73","author":"Edwards-Ingram","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.medmal.2015.12.003","article-title":"Septic shock due to Saccharomyces boulardii","volume":"46","author":"Ellouze","year":"2016","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0265","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","article-title":"Invasive Saccharomyces infection: a comprehensive review","volume":"41","author":"Enache-Angoulvant","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5578\/mb.6970","article-title":"Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment","volume":"48","author":"Eren","year":"2014","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0275","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3390\/ijerph110504745","article-title":"Microorganisms with claimed probiotic properties: an overview of recent literature","volume":"11","author":"Fijan","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0280","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jinf.2006.01.019","article-title":"Saccharomyces cerevisiae fungemia in an immuno compromised patient not treated with Saccharomyces boulardii preparation","volume":"54","author":"Graf","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0285","first-page":"575","article-title":"Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient","volume":"13","author":"Hamoud","year":"2011","journal-title":"IMAJ"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0290","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/429926","article-title":"Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration","volume":"40","author":"Herbrecht","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0295","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00134-002-1267-9","article-title":"Seven cases of fungemia with Saccharomyces boulardii in critically ill patients","volume":"28","author":"Lherm","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0300","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/cc6843","article-title":"Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin","volume":"12","author":"Lolis","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0305","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2016.12.004","article-title":"Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use","volume":"87","author":"Martin","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0310","first-page":"459","article-title":"Identification and genetic inter-relationship analysis of Saccharomyces yeasts by arbitrary primed PCR fingerprinting","volume":"42","author":"Mozina","year":"1995","journal-title":"Acta Chimica Slovenica"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0315","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0320","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3389\/fmicb.2015.01522","article-title":"Opportunistic strains of Saccharomyces cerevisiae: a potential risk sold in food products","volume":"6","author":"P\u00e9rez-Torrado","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0325","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/tid.12384","article-title":"Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients","volume":"17","author":"Popiel","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0330","first-page":"63","article-title":"Saccharomyces cerevisiae var. boulardii as a eukaryotic probiotic and its therapeutic functions","volume":"2","author":"Pourjafar","year":"2015","journal-title":"J Mycol Res"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0335","first-page":"148","article-title":"Effects of S. cerevisiae var. boulardii in gastrointestinal disorders","volume":"21","author":"Profir","year":"2015","journal-title":"J Agroalimentary Proc Technol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004836-200301000-00013","article-title":"Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment inimmunocompromised patients","volume":"36","author":"Riquelme","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0345","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/myc.12604","article-title":"Seven cases of Saccharomyces fungaemia related to use of probiotics","volume":"60","author":"Roy","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/039463201402700120","article-title":"Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum","volume":"27","author":"Santino","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0355","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1117018109","article-title":"Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi","volume":"109","author":"Schoch","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0360","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12098-008-0119-1","article-title":"Probiotic use in the critically ill","volume":"75","author":"Singhi","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0365","series-title":"Probiotics in critically ill children","first-page":"5","author":"Singhi","year":"2016"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0370","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1111\/j.1439-0507.2010.01963.x","article-title":"Probiotic sepsis due to Saccharomyces fungaemia in a critically ill burn patient","volume":"54","author":"Stefanatou","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0375","first-page":"2012","article-title":"Saccharomyces boulardii fungemia caused by treatment with a probioticum","author":"Thygesen","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.mycmed.2017.09.003_bib0380","first-page":"47","article-title":"Saccharomyces boulardii effects on gastrointestinal diseases","volume":"11","author":"Zanello","year":"2009","journal-title":"Curr Issues Mol Biol"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317301087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317301087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:18:20Z","timestamp":1761110300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523317301087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1156523317301087"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.09.003","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}